Origin and Evolution of Induced Pluripotent Stem Cells (IPSCs)

The discovery of induced pluripotent stem cells (iPSCs) revolutionized cell biology, offering groundbreaking potential for regenerative medicine and therapeutic applications. By reprogramming adult somatic cells into a pluripotent state through the introduction of embryonic transcription factors, iPSCs provided unprecedented opportunities to study human diseases and develop autologous cell-based therapies.

The development of iPSCs Technology stems from three pivotal advancements: (a) Nuclear Reprogramming, which demonstrated that differentiated cells retain genetic information essential for development (b)    Master Transcription Factors where MyoD was shown to convert fibroblasts into muscle cells, introducing the concept of "master regulators" capable of defining cell fates.(c) ESC Culture Advances: The establishment of embryonic stem cells (ESCs) in 1981 and 1998 provided insights into pluripotency and its maintenance, laying the groundwork for identifying key transcription factors required for iPSC generation. Synthesizing these advancements, Scientists identified four transcription factors (Oct4, Sox2, Klf4, and c-Myc) to generate mouse iPSCs in 2006 and human iPSCs in 2007.The above development promoted research in modeling development and disease, drug discovery, cell therapy, complex tissue model system.

Despite advances, iPSCs face challenges, including the immature state of derived cells, which limits their utility for age-related disease modeling. Researchers are addressing this through methods like mitochondrial stress induction and direct trans differentiation. Advances in CRISPR/Cas9 editing, multiomics, and automation of organoid production are also enhancing iPSC applications. .iPSCs have revolutionized developmental biology, disease modeling, and regenerative medicine, driving progress toward personalized and precision medicine. With continued advancements, iPSC technology holds the promise to deliver tailored therapies for complex diseases, transforming the future of healthcare.